Ftse Mib
34.423,23
-0,52%
DAX
18.662,59
-0,34%
S&P 500
5.321,41
0,25%
NASDAQ
16.832,62
0,22%
Bitcoin
69.907,90
-0,32%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ 60 Degrees Pharmaceuticals Inc (SXTP) 60 Degrees Pharmaceuticals Inc (SXTP) Notizie

60 Degrees Pharmaceuticals Inc

SXTP
0,2791
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/5/202413:59GLOBE60 Degrees Pharmaceuticals Funds Babesia spp Testing in..
15/5/202419:45GLOBE60 Degrees Pharmaceuticals Announces First Quarter 2024..
08/5/202413:59GLOBE60 Degrees Pharmaceuticals Outlines Upcoming Clinical Trial..
02/5/202413:59GLOBE60 Degrees Pharmaceuticals Receives FDA Comments on..
03/4/202413:58GLOBE60 Degrees Pharmaceuticals to Sponsor Pilot Study of..
14/3/202412:59GLOBE60 Degrees Pharmaceuticals Announces Communication from the..
20/2/202422:00EDGAR2Form 8-K - Current report
20/2/202413:59GLOBE60 Degrees Pharmaceuticals to Sponsor Pre-Clinical Studies..
08/2/202413:59GLOBE60 Degrees Pharmaceuticals Appoints Kristen Landon as Chief..
02/2/202421:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202421:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202418:00PRNUSWallachBeth Capital Announce Closing of 60 Degrees..
31/1/202417:15GLOBE60 Degrees Pharmaceuticals Announces Closing of $2.4 Million..
30/1/202415:45PRNUSWallachBeth Capital Announces Pricing of 60 Degrees..
30/1/202415:00GLOBE60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million..
30/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
22/1/202423:01EDGAR2Form 8-K - Current report
22/1/202413:59GLOBE60 Degrees Pharma Plans Pivotal Babesiosis Study with..
16/1/202420:56EDGAR2Form 8-K - Current report
16/1/202413:59GLOBE60 Degrees Pharma Regains Compliance with Nasdaq Listing..
26/12/202313:59GLOBE60 Degrees Pharma Announces IRB Approval of Phase IIA Study..
15/11/202313:29GLOBE60 Degrees Pharma Announces Type C Meeting with FDA to..
19/10/202314:31GLOBE60 Degrees Pharma to Present Review of Safety, Efficacy Data..
12/10/202322:16GLOBE60 Degrees Pharmaceuticals Suspends Phase IIB Study of..
18/9/202322:16GLOBE60 Degrees Pharma Withdraws COVID Phase IIB IND, Will..
06/9/202313:31GLOBE60 Degrees Pharmaceuticals to Participate in H.C. Wainwright..
30/8/202313:32GLOBE60 Degrees Pharmaceuticals Study Results Published by New..
22/8/202313:31GLOBE60 Degrees Pharmaceuticals Receives Additional U.S. Patent..
15/8/202313:31GLOBE60 Degrees Pharmaceuticals Registers ACLR8-LR, a Phase IIB..
31/7/202313:59GLOBE60 Degrees Pharmaceuticals Awarded Canadian Patent Covering..
14/7/202319:30PRNUSWallachBeth Capital Announce Closing Of 60 Degrees..
14/7/202318:39GLOBE60 Degrees Pharmaceuticals Announces Closing of Initial..
12/7/202319:45PRNUSWallachBeth Capital Announce Pricing Of 60 Degrees..
12/7/202318:29GLOBE60 Degrees Pharmaceuticals Announces Pricing of Initial..
Apertura: Min: Max:
Chiusura: 0,2791

La tua Cronologia

NASDAQ
SXTP
60 Degrees Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network